Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Preliminary data suggests fewer than 30% of patients are still on an AOM after 1 year, with abandonment and discontinuation rates highly sensitive to costs
When does the clock start
GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care This week on On The Pen , we break down a rare FDA walk-back on GLP-1 safety labeling, major pharma signals coming out of JPM 2026, and the growing tension between patient access and legislative efforts that could restrict compounding
doi:10.1126/science.299.5608.846 Authesserre N, et al
Results of clinical trials suggest that ORTHO EVRA may be less effective in women with body weight 198 lbs
US$ 25.43
US$ 20.83
US$ 24.91
US$ 28.98
US$ 23.37
US$ 25.42
US$ 26.61
